operable breast cancer
The decision making process for senior cancer patients: treatment allocation of older women with operable breast cancer in the UK
14
The Effect of Overweight on The Risk of Recurrence in Tunisian Patients with Operable Breast Cancer
6
<p>Pathologic Response After Weekly Paclitaxel versus Docetaxel in Operable Breast Cancer</p>
8
Ambulatory sentinel lymph node biopsy preceding neoadjuvant therapy in patients with operable breast cancer: a preliminary study
6
Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial
30
High expression of metabolic enzyme PFKFB4 is associated with poor prognosis of operable breast cancer
8
Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial
9
Factors that predict recurrence later than 5 years after initial treatment in operable breast cancer
8
Case mix does not fully explain variation in rates of non surgical treatment of older women with operable breast cancer
12
Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial
9
Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial
11
Window of opportunity Study Testing the Antiproliferative Effect of Atorvastatin in Egyptian Patients with Operable Breast Cancer
7
Hypothyroidism and the risk of breast cancer recurrence and all cause mortality a Danish population based study
11
Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group
11
HER2 and TOP2A in high risk early breast cancer patients treated with adjuvant epirubicin based dose dense sequential chemotherapy
21
Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus)
36
A Study on incidence of operable carcinoma breast
100
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
10
Feasibility of Concurrent Radiotherapy and Paclitaxel Based Chemotherapy after Conservative Surgery for Breast Cancer
11
Prognostic Significance of Architectural Invasive and Proliferative features in Invasive Breast Carcinoma.
85